MRI contrast agent for molecular imaging of the HER2/neu receptor using targeted magnetic nanoparticles
β Scribed by Samira Rasaneh; Hossein Rajabi; Mohammad Hossein Babaei; Shahram Akhlaghpoor
- Publisher
- Springer Netherlands
- Year
- 2010
- Tongue
- English
- Weight
- 427 KB
- Volume
- 13
- Category
- Article
- ISSN
- 1388-0764
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
MR molecular imaging is an exciting new frontier in the biomedical applications of MR. One of the clinically relevant targets is the tyrosine kinase Her-2/neu receptor, which has a significant role in staging and treating breast cancer. In this study Her-2/neu receptors were imaged in a panel of bre
Molecular imaging of tumor antigens using immunospecific magnetic resonance (MR) contrast agents is a rapidly evolving field, which can potentially aid in early disease detection, monitoring of treatment efficacy, and drug development. In this study, we designed, synthetized, and tested in vitro two
## Abstract Superparamagnetic iron oxide particles, a new class of contrast agents for MRI, are extremely good enhancers of proton relaxation. However, the development of such particle systems has resulted in a wide range of preparations whose physicoβchemical properties differ greatly. We have con
## Abstract Pretargeting of receptors is a useful approach in molecular imaging and therapy to reduce background noise or toxicity and enhance selectivity. In this study a threeβstep pretargeting approach that includes a biotinylated antibody, avidin/streptavidin, and a biotinylated imaging agent i